Neuron23 Stock

neuron23.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $213.61MM

Neuron23 develops precision medicines for genetically defined neurological and immunological diseases.

Register for Details

For more details on financing and valuation for Neuron23, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Neuron23.

Register Today

Other companies like Neuron23 in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B